v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss for the year $ (35,444,361) $ (11,155,516)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 1,512,194 713,119
Non-cash interest expense 429,061 74,005
Change in operating lease right-of-use assets 97,838 88,234
Change in fair value of debentures 583,823 0
Loss of extinguishment of debentures 25,000 0
IPR&D - Teverelix 8,717,475 0
Foreign exchange gain/loss 41,947 0
Loss on SEPA settlements 278,854 0
Issuance cost related to SEPA 300,000 0
Cost of issuance of debentures 111,725 0
Changes in operating assets and liabilities:    
Prepaid expenses 352,825 (1,040,265)
Deferred financing costs (99,305) 0
Accounts payable 923,552 808,745
Accrued expenses and other current liabilities (438,802) 358,018
Operating lease liability (142,612) (70,080)
Related party payable (25,983) (23,491)
Net cash used in operating activities (22,776,769) (10,247,231)
Cash flows from financing activities    
Proceeds from issuance of convertible promissory notes 0 5,172,500
Proceeds from initial public offering, net of offering expenses 0 2,049,716
Proceeds from issuance of common shares and warrants, net of issuance costs 9,790,015 5,470,000
Proceeds from issuance of debentures 11,866,293 0
Repayment of the debentures and other loan (7,391,107) 0
Proceeds from issuance of common shares under SEPA 8,427,416 0
Proceeds from exercise of warrants 9,874,998 0
Proceeds from exercise of stock options 162,400 0
Costs to issue debentures (136,726) 0
Issuance costs for common shares (653,504) 0
Net cash provided by financing activities 31,939,785 12,692,216
Cash flows from investing activities    
Net cash paid for Antev asset acquisition including transaction costs (4,619,152) 0
Net cash used in investing activities (4,619,152) 0
Foreign currency effect on cash and cash equivalents (2,969) 0
Net increase in cash and cash equivalents during the year 4,540,895 2,444,985
Cash and cash equivalents, beginning of the year 4,164,323 1,719,338
Cash and cash equivalents, end of the year 8,705,218 4,164,323
Supplemental information    
Cash paid for interest 221,663 40,563
Supplemental disclosure of non-cash investing and financing activities    
Right-of-use assets obtained in exchange for lease liabilities 0 356,805
Deemed dividend on warrant inducement 11,837,298 0
Issuance costs included in accounts payable 95,360 265,025
Shares issued for Antev asset acquisition 2,129,410 0
Shares to be issued for Antev asset acquisition 313,934 0
Issuance of shares related to SEPA agreement 300,000 0
Accrued interest converted into common shares $ 0 $ 38,462